Connect with us

Economics

3 Popular Penny Stocks to Watch in July 2022

Check these three penny stocks out for your watchlist right now
The post 3 Popular Penny Stocks to Watch in July 2022 appeared first on Penny Stocks to…

Published

on

Are These Popular Penny Stocks on Your Buy List Right Now?

While finding popular penny stocks to buy may seem challenging, there are a few key ways to identify penny stocks that have the potential to be big winners. Starting out, it is always best to identify your trading strategy. This will help you know how to find penny stocks that fit your trading style. While it may seem difficult at first, knowing what your risk tolerance is and how to use that as an advantage, will help you in the long run. 

[Read More] Can These Penny Stocks to Watch Continue to Climb?

Right now, we have numerous factors that are all contributing to the highly speculative and volatile investing environment. And because of this, it is more pertinent than ever to know how to find penny stocks that have the potential to make you big profits. If you’re looking for popular penny stocks to buy, there are plenty of aspects to keep in mind. 

For one, popular penny stocks tend to be extremely volatile. This is due to the low prices per share, and the amount of news circulating about them. However, this volatility can also lead to big losses if you’re not careful. So, keeping all of this in mind, let’s take a look at three popular penny stocks to add to your watchlist right now.

3 Popular Penny Stocks For Your Watchlist 

  1. TDH Holdings Inc. (NASDAQ: PETZ)
  2. Avaya Holdings Corp. (NYSE: AVYA)
  3. Regis Corp. (NYSE: RGS

TDH Holdings Inc. (NASDAQ: PETZ) 

During trading and into after hours, shares of PETZ stock shot up by an explosive 54% and more than 15% respectively. These are major gains that bring it to over $3.41 per share. And with a six month drop of over 95%, these upticks are a welcomed advancements for investors and the company alike. 

So, why are shares of PETZ stock climbing right now? Well, to understand this, we have to take a closer look at the company and its recent announcements. Around two weeks ago, the company announced a 1-20 reverse stock split. The goal of this was to regain compliance with the NASDAQ minimum big listing requirement. 

[Read More] 4 Low Float Penny Stocks To Watch This Week

Since then, the company has managed to climb over $1 per share, which means it is no longer at risk of being de-listed. Despite this, PETZ stock still carries a very sizable amount of volatility. And for that reason, risk averse investors may want to avoid it. However, if you are looking for volatile penny stocks, PETZ could be worth adding to your penny stocks watchlist

Avaya Holdings Corp. (NYSE: AVYA) 

With over 9.5% in gains during trading and more than 2.9% in gains during after hours, many investors are watching AVYA stock right now. Despite a six month drop of over 80%, shares of AVYA stock have climbed by over 15% in the last month. This is exciting news and shows that there is some bullish momentum for AVYA right now. On June 21st, the company announced that it would showcase contact center solutions for customers. 

“Today’s customer knows what they want, exactly when and how they want it, and has high expectations for each interaction with a brand. Giving them what they want, however, will take brands moving to a total and effortless experience across applications, devices and interactions.

This type of experience is only possible when cloud capabilities, AI and automation are mixed into every customer touchpoint and digital channel, and this is what Avaya OneCloud CCaaS provides.”

Paul Lang, Head of Contact Center Solutions Marketing, Avaya

This is an exciting update for the company and one that investors should consider. Whether this makes it a buy or not, is up to you. 

Penny_Stocks_to_Watch_Avaya

Regis Corp. (NYSE: RGS) 

On June 23rd, RGS stock managed to shoot up by over 6.5% with a 3% gain in after hours. In the past five days, RGS stock has exploded by more than 75%, which is no small feat. The most recent news from the company came on June 14th when it announced that it received a continued listing notice from the NYSE. It stated that it has to have a minimum of $1 per share for 30 consecutive trading days. 

If you’re not familiar, Regis is a leader in the beauty salon industry and owns concepts like Supercuts, SmartStyle, Cost Cutters, and more. As a result of the pandemic slowing down in severity, the company has seen greatly improved numbers for its business. Although it is highly volatile, its recent upticks are exciting. Considering that, will it be on your list of penny stocks to buy or not?

Penny_Stocks_to_Watch_Regis

Are Penny Stocks Worth Buying or Not?

Whether or not penny stocks are worth it is up to you. To understand whether or not it is worth it, investors need to consider exactly what is going on in the world and how to take advantage. The main factors at play in the stock market right now include rising inflation and climbing interest rates.

[Read More] What to Know About Buying Penny Stocks on June 23rd

All of this has made investing in penny stocks and blue chips very difficult. But, amidst this high volatility is also the potential to make money with the large swings. So, considering this, do you think penny stocks are worth buying right now or not?

The post 3 Popular Penny Stocks to Watch in July 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Government

New Hampshire Governor Vetoes Ivermectin Bill

New Hampshire Governor Vetoes Ivermectin Bill

Authored by Alice Giordano via The Epoch Times (emphasis ours),

New Hampshire’s Republican…

Published

on

New Hampshire Governor Vetoes Ivermectin Bill

Authored by Alice Giordano via The Epoch Times (emphasis ours),

New Hampshire’s Republican Gov. Chris Sununu vetoed a bill that would have made Ivermectin available without a prescription.

Ivermectin tablets packaged for human use. (Natasha Holt/The Epoch Times)

The Republican governor vetoed the bill on June 24, the same day that the U.S. Supreme Court overturned Roe v. Wade. Some fellow Republicans questioned the timing.

It certainly seemed like a convenient way to bury a veto of a bill that won support from the vast majority of Republicans in New Hampshire,” JR Hoell, co-founder of the conservative watchdog group RebuildNH, told The Epoch Times.

Hoell is a former four-term House Republican planning to seek re-election after a four-year hiatus from the the New Hampshire legislature.

Earlier this year, the New Hampshire Department of Children Youth and Family (DCYF) tried to take custody of Hoell’s 13-year old son after a nurse reported him for giving human-grade ivermectin to the teen months earlier.

Several states have introduced bills to make human-grade ivermectin available without a prescription at a brick and mortar store. Currently, it can be ordered online from another country. In April, Tennessee became the the first state to sign such a measure into law. New Hampshire lawmakers were first to introduce the idea.

Both chambers of the state’s Republican controlled legislature approved the bill.

In his statement explaining the veto, Sununu noted that there are only four other controlled medications available without a prescription in New Hampshire and that each were only made available after “rigorous reviews and vetting to ensure” before being dispensed.

“Patients should always consult their doctor before taking medications so that they are fully aware of treatment options and potential unintended consequences of taking a medication that may limit other treatment options in the future,” Sununu said in his statement.

Sununu’s statement is very similar to testimony given by Paula Minnehan, senior vice president of state government regulations for the New Hampshire Hospital Association, at hearings on the bill.

Minnehan too placed emphasis on the review that went into the four prescription medications the state made available under a standing order. They include naloxone, the generic name for Narcan, which is used to counter opioid overdoses, hormone replacement therapy drugs, and a prescription-version of the morning after pill.

It also includes a collection of smoking cessation therapy drugs like Chantix, which has been linked to suicide, depression, and other neuropsychiatric conditions. Last year, Pfizer, the leading maker of the FDA-approved drug, conducted a voluntarily recall of Chantix. Narcan has also been linked to deaths caused by severe withdrawals that have led to acute respiratory distress.

Rep. Melissa Blasek, a Republican co-sponsor of the New Hampshire ivermectin bill, told The Epoch Times, that one could veto any drug-related bill under the pretense of overdose concerns.

The reality is you can overdose on Tylenol,” she said. “Ivermectin has one of the safest track records of any drug.”

The use of human-grade ivermectin became controversial when some doctors began promoting it for the treatment and prevention of COVID-19. Government agencies including the FDA and CDC issued warnings against its use while groups like Front Line COVID-19 Critical Care Alliance (FLCCC) heavily promoted it.

Some doctors were  disciplined for prescribing human-grade ivermectin for COVID-19 including a Maine doctor whose medical license was suspended by the state.

Read more here...

Tyler Durden Thu, 06/30/2022 - 20:30

Read More

Continue Reading

Economics

The One Housing Chart That Shows A ‘Buyer’s Market’ Has Returned

The One Housing Chart That Shows A ‘Buyer’s Market’ Has Returned

The red hot pandemic-era housing market is cooling as historically tight…

Published

on

The One Housing Chart That Shows A 'Buyer's Market' Has Returned

The red hot pandemic-era housing market is cooling as historically tight available inventory shows signs of reversing. 

An affordability crisis has removed millions of new home buyers as the number of active US listings soared 18.7% in June from a year earlier, the most significant increase in Realtor.com's data going back to 2017, according to Bloomberg. The days of insane bidding wars, waiving home inspections, and putting in an offer 20% or more over the list price appear to be over. In other words, a buyer's market could be emerging. 

"While we anticipate that more inventory will eventually cool the feverish pace of competition, the typical buyer has yet to see meaningful relief from quick-selling homes and record-high asking prices," said Danielle Hale, chief economist for Realtor.com. 

Austin, Texas; Phoenix, Arizona; and Raleigh, North Carolina saw active listings more than double from a year ago. Nashville, Tennessee, active listings jumped 86%, and 72% in the Riverside, California. 

The Federal Reserve's most aggressive tightening campaign sent the 30-year fixed-loan mortgage rate from 3% to over 6% this year (back in March, we warned coming rate explosion would trigger a housing affordability crisis), removing millions of new home buyers who can't afford the cost of homeownership as the median existing-home sales price was around $407k in May. 

Even though inventory is historically tight, supply is expected to increase in markets across the country as demand for loan applications among prospective buyers slumps. Fewer buyers equal more inventory. 

The takeaway is that inventory is rising as homes stay on the market longer because demand evaporated thanks to the housing affordability crisis -- this could mean a housing top is nearing. 

Tyler Durden Thu, 06/30/2022 - 18:50

Read More

Continue Reading

Economics

States Need To Avoid ‘Cures’ That Can Make Inflation Worse

States Need To Avoid ‘Cures’ That Can Make Inflation Worse

Authored by Regina M. Egea and Danielle Zanzalari via RealClearPolicy.com,

Across…

Published

on

States Need To Avoid 'Cures' That Can Make Inflation Worse

Authored by Regina M. Egea and Danielle Zanzalari via RealClearPolicy.com,

Across the United States, state governments are awash in cash. In a sharp contrast, American taxpayers are enduring a rate of inflation unseen in four decades, with the costs of everything from food to gasoline at record highs.

In our home state of New Jersey, Trenton is looking at an unprecedented surplus of $8 billion through a combination of increased tax revenue, federal pandemic aid and borrowing.

A natural impulse among residents and policymakers is to offer residents “relief” in the form of rebate checks.

The reality is that relying exclusively on rebates or direct cash transfers to individuals will only lead to more inflation as this puts more money in consumers’ hands exacerbating the same problem as today - too many dollars chasing too few goods.

Rather, it is prudent that states focus on long-term investment and responsible budgeting to ensure economic growth now and in the future. This is especially important in high tax, big spending states due to the greater flexibility in work arrangements that have exposed the reality that wealth is mobile.

With more residents fleeing high tax states to low tax states, states will need to reevaluate their tax and regulatory climate to stay competitive. 

Regulation can raise the costs for consumers and slow job growth. A series of studies shows the regulation raises prices and worsens poverty.

Working with local governments to revisit restrictive laws that contribute to higher housing prices, such as building height restrictions and zoning rules, as well as removing unnecessary restrictions on business operations will lead to more economic growth.

Another way states can aid productivity and long-term economic growth with their temporary budget surplus, is to fund training programs for middle-skilled jobs.

Nearly every industry has experienced labor shortages and that reality is especially acute in trades like auto, refrigeration, HVAC, electrical, welding, and manufacturing.

States can invest in these skills through high school and vocational school programs. With college borrowing costs astronomically high, this encourages individuals to pursue careers that are lucrative and budget friendly, as well as fill the over 75,000 job openings that our state of New Jersey is projected to need in just a few years.

To further long-term economic growth many states should also concentrate on fixing their unfunded pension liabilities for public employees. This impacts red and blue states alike, with massive liabilities in California ($1.53 trillion), Illinois ($533.72 billion), Texas ($529.70 billion), New York ($508.70 billion) and Ohio ($429.53 billion). Here in New Jersey, our liability is nearly $40,000 for every resident of the state, which can dramatically deter future growth. Beyond using some of states’ budget surplus to shore up pension liabilities, states should move public employees to defined contribution plans, which are used by more than 100 million Americans. These are found to have better investment returns than state-wide pension plans and cost taxpayers less.

Our final recommendation is perhaps our most important: Save for a rainy day. If the U.S. economy enters into a recession, this will mean fewer jobs and less tax revenue for states. To prepare for the future when states again face a budget shortfall, which may be sooner than we think, states should follow best practices of reserving 10% of their budget in a rainy day fund, to sustain essential programs should a downturn occur in the future.

As state leaders consider their budgets, they should focus on long-term economic growth initiatives. Proposals like funding middle-skilled job trainings ensure workers are ready for the next decade, whereas eliminating unnecessary regulations and focusing on pro-growth tax reforms encourages residents to build businesses and create jobs. Lastly, taking care of state finances by properly funding state employees’ retirement plans and saving for a rainy day will ensure that no state is left behind in the next economic downturn.

Tyler Durden Thu, 06/30/2022 - 17:50

Read More

Continue Reading

Trending